Viral Conjunctivitis

Hazel Everitt,

Hazel Everitt

Search for more papers by this author

Hazel Everitt,

Hazel Everitt

Search for more papers by this author

Book Editor(s):Richard Wormald,

Richard Wormald

Consultant Ophthalmologist, Moorfields Eye Hospital, Honorary Senior Lecturer, London School of Hygiene and Tropical Medicine and Coordinating Editor, Cochrane Eyes and Vision, Group, London, UK

Search for more papers by this author

Liam Smeeth,

Liam Smeeth

Senior Lecturer in Clinical Epidemiology, London School of Hygiene and Tropical Medicine, General Practitioner, London and Editor, Cochrane Eyes and Vision Group, London, UK

Search for more papers by this author

Katherine Henshaw,

Katherine Henshaw

Review Group Coordinator, Cochrane Eyes and Vision Group, London, UK

Search for more papers by this author

Anupa Shah,

Anupa Shah

Trial Search Coordinator, Cochrane Eyes and Vision Group, London, UK

Search for more papers by this author

First published: 01 January 2005

https://doi.org/10.1002/9780470698709.ch6

Summary

This chapter contains section titled:

Background
Presentation
Diagnosis
Prognosis
Treatment options
The evidence
The evidence
The evidence
The evidence
Discussion
Implications for Practice
Implications for Research
References

References

Sheldrick JH, Wilson AD, Vernon SA, Sheldrick CM. Management of ophthalmic disease in general practice. Br J Gen Pract 1993; 43: 459–62.
CAS PubMed Web of Science® Google Scholar
Mahajan VM. Acute bacterial infections of the eye: their aetiology and treatment. Br J Ophthalmol 1983; 67: 191–4.
10.1136/bjo.67.3.191
CAS PubMed Web of Science® Google Scholar
Wilson A. The red eye: a general practice survey. J R Coll Gen Pract 1987; 37: 62–4.
CAS PubMed Web of Science® Google Scholar
Donahue S, Khoury J, Kowalski R. Common ocular infections: a prescriber's guide. Drugs 1996; 52: 527–39.
10.2165/00003495-199652040-00006
Web of Science® Google Scholar
Isenberg SJ, Apt L, Valenton M et al. A controlled trial of povidoneiodine to treat infectious conjunctivitis in children. Am J Ophthalmol 2002; 134: 681–8.
10.1016/S0002-9394(02)01701-4
CAS PubMed Web of Science® Google Scholar
Wilhelmus K, Dunkel E, Herson J. Topical human fibroblast interferon for acute adenoviral conjunctivitis. Graefe's Arch Clin Exp Ophthalmol 1987; 225: 464.
10.1007/BF02334177
Web of Science® Google Scholar
Reilly S, Dhillon B, Nkanza K et al. Adenovirus type 8 keratoconjunctivitis - an outbreak and its treatment with topical human fibroblast interferon. J Hyg Camb 1986; 96: 557–75.
10.1017/S0022172400066365
CAS PubMed Web of Science® Google Scholar
Adams C, Cohen E, Albrecht J, Laibson P. Interferon treatment of adenoviral conjunctivis. Am J Ophthalmol 1984; 98: 429–32.
10.1016/0002-9394(84)90125-9
PubMed Web of Science® Google Scholar
Stansfield S, De La Pena W, Koenig S et al. Human leucocyte interferon in the treatment and prophylaxis of acute haemorrhagic conjunctivitis. J Infect Dis 1984; 149: 822–3.
10.1093/infdis/149.5.822
CAS PubMed Web of Science® Google Scholar
Sundmacher R, Wigand R, Cantell K. The value of exogenous interferon in adenovirus keratoconjunctivitis. Graefe's Arch Clin Exp Ophthalmol 1982; 218: 139–40.
10.1007/BF02215650
CAS PubMed Web of Science® Google Scholar
Dudgeon J, Bhargava S, Ross C. Treatment of adenovirus infection of the eye with 5-iodo-2-deoxyuridine. Br J Ophthalmol 1969; 53: 533.
10.1136/bjo.53.8.530
Web of Science® Google Scholar
Marmion V. Treatment of adenovirus type 8 keratoconjunctivitis. Trans Ophthalmol Soc UK 1972; 92: 619–23.
CAS PubMed Google Scholar
Pavan-Langston D, Dohlman CH. A double blind clinical study of adenine arabinosine therapy of viral keratoconjunctivitis. Am J Ophthalmol 1972; 74: 81–8.
10.1016/0002-9394(72)91130-0
CAS PubMed Web of Science® Google Scholar
Ward J, Siojo L, Waller S. A prospective masked clinical trial of trifluridine, dexamethasone and artificial tears in the treatment of epidemic keratoconjunctivitis. Cornea 1993; 12: 216–21.
10.1097/00003226-199305000-00006
CAS PubMed Web of Science® Google Scholar
Kosrirukvongs M. Topical piroxicam and conjunctivitis. J Med Assoc Thau 1997; 80: 287–92.
CAS PubMed Google Scholar
Shiuey Y, Ambati B, Adamis AP. A randomized, double-masked trial of topical ketorolac versus artificial tears for treatment of viral conjunctivitis. Ophthalmology 2000; 107: 1512–17.
10.1016/S0161-6420(00)00177-9
CAS PubMed Web of Science® Google Scholar

Evidence‐based Ophthalmology